SCHEMBL8273584

SCHEMBL8273584

Nc1cc(F)ccc1N1CCC(CNC(=O)[C@H](O)[C@@H](O)C(=O)N2CCC3(CCNCC3)C2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.37
▸ HDAC2 Q92769 6/20 0.37
▸ HDAC1 Q13547 3/20 0.37
▸ ADAM17 P78536 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ USP2 O75604 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ EIF4E P06730 1/20 0.35
▸ MKNK1 Q9BUB5 1/20 0.35
▸ MKNK2 Q9HBH9 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ MGLL Q99685 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ HDAC3 O15379 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ HSD11B1 P28845 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8213705 0.89 ADAM17 (0.45) NAMPTADAM17ALDH1A1USP2CYP2D6
SCHEMBL8273312 0.88 ADAM17 (0.41) NAMPTADAM17USP2CYP2D6CYP3A4
SCHEMBL8273588 0.88 ADAM17 (0.40) HDAC2HDAC1ADAM17ALDH1A1EIF4E
SCHEMBL8273443 0.88 DPP4 (0.41) ADAM17ALDH1A1GAAHTTL3MBTL1
SCHEMBL8273310 0.84 GAA (0.44) NAMPTADAM17ALDH1A1GAAHTT
SCHEMBL8273591 0.84 ADAM17 (0.43) NAMPTHDAC2HDAC1ADAM17ALDH1A1
SCHEMBL8273592 0.83 HTT (0.46) NAMPTADAM17ALDH1A1GAAHTT
SCHEMBL8273579 0.81 CTSS (0.41) NAMPTADAM17ALDH1A1GAAHTT
SCHEMBL8273311 0.81 ADAM17 (0.41) HDAC2HDAC1ADAM17ALDH1A1HDAC3
SCHEMBL8273578 0.81 ADAM17 (0.39) HDAC2HDAC1ADAM17ALDH1A1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7652020-B2 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction SCHERING CORPORATION (US) 2010-01-26 — — US disclosed
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 — — WO disclosed
Send feedback